235 related articles for article (PubMed ID: 6270796)
21. [Hairy cell leukemia (leukemic reticuloendotheliosis) (author's transl)].
Rupniewska ZM
Przegl Lek; 1981; 38(7):555-60. PubMed ID: 7025110
[No Abstract] [Full Text] [Related]
22. Hairy cell leukemia: reevaluation of cell surface features under the scanning electron microscope, using the "GTGO" air drying and critical point drying procedures.
Gamliel H; Golomb HM; Gurfel D; Hiraoka A; Rosner MC; Polliack A
Scan Electron Microsc; 1985; (Pt 4):1665-78. PubMed ID: 3912968
[TBL] [Abstract][Full Text] [Related]
23. [Hairy cell leukemia of European-American type with dual T and B-cell phenotype].
Kurosawa M; Maekawa I; Kawamura T; Miyake T; Machii T; Kitani T; Tokumine Y; Kawa K
Rinsho Ketsueki; 1989 Jun; 30(6):892-7. PubMed ID: 2795901
[TBL] [Abstract][Full Text] [Related]
24. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
Zák P; Chrobák L; Dĕdic K; Podzimek K
Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
[TBL] [Abstract][Full Text] [Related]
25. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
[TBL] [Abstract][Full Text] [Related]
26. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
27. [European-American-type hairy cell leukemia without splenomegaly, treated successfully with deoxycoformycin].
Muta T; Okamura T; Oshima K; Kikuchi M; Niho Y
Rinsho Ketsueki; 2001 May; 42(5):426-31. PubMed ID: 11452464
[TBL] [Abstract][Full Text] [Related]
28. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
29. [Morphological and cytochemical variability of hairy cells (author's transl)].
Woessner S; Lafuente Rodes R; Rozman C; Sans-Sabrafen J
Sangre (Barc); 1978; 23(2):173-80. PubMed ID: 653552
[No Abstract] [Full Text] [Related]
30. Immunogold labelling of leukemic hairy cells with the B-ly7 monoclonal antibody: an SEM and TEM study.
de Harven E; Christensen H; Poppema S; Scott JG
Microsc Res Tech; 1994 Jul; 28(4):356-67. PubMed ID: 7919522
[TBL] [Abstract][Full Text] [Related]
31. [Question of differential diagnosis in a case of chronic B-cell lymphopathy].
Moccia F; Casti P; Morra L
Clin Ter; 1993 May; 142(5):421-31. PubMed ID: 8339525
[TBL] [Abstract][Full Text] [Related]
32. Hematology problem.
Bell A
Am J Med Technol; 1980 Oct; 46(10):716-8. PubMed ID: 7211936
[TBL] [Abstract][Full Text] [Related]
33. [Progress in the treatment of hairy cell leukemia. Subcutaneous administration of 2-chloro-deoxy-adenosine for 7 days].
Heldal D; Tjønnfjord GE; Evensen SA; Juliusson G
Tidsskr Nor Laegeforen; 1994 Mar; 114(7):800-3. PubMed ID: 7912011
[TBL] [Abstract][Full Text] [Related]
34. Phase II trials of pentostatin (Nipent) in hairy cell leukemia.
Kraut EH
Semin Oncol; 2000 Apr; 27(2 Suppl 5):27-31. PubMed ID: 10877048
[TBL] [Abstract][Full Text] [Related]
35. [Hairy cell leukaemia. I. Clinical features, cytochemistry, phagocytosis, establishment of permanent growing cell lines (author's transl)].
Heyden HW; Waller HD; Pape GR; Benöhr HC; Braun HJ; Wilms K; Rieber EP; Riethmüller G
Dtsch Med Wochenschr; 1976 Jan; 101(1):3-8. PubMed ID: 1245150
[TBL] [Abstract][Full Text] [Related]
36. Fine needle aspiration of the spleen in hairy cell leukemia. A case report.
Pinto RG; Rocha PD; Vernekar JA
Acta Cytol; 1995; 39(4):777-80. PubMed ID: 7631555
[TBL] [Abstract][Full Text] [Related]
37. [A hairy B cell lymphoproliferative disorder resembling hairy cell leukemia].
Yagi Y; Sakabe H; Kakinoki R; Yoshikawa K; Inoue T; Fujiyama Y; Machii T
Rinsho Ketsueki; 2004 Apr; 45(4):312-5. PubMed ID: 15168448
[TBL] [Abstract][Full Text] [Related]
38. Absence of neutral protease and alkaline phosphatase in neutrophils of a case of hairy cell leukemia.
Zeya HI; Keku E; Richards F; Spurr CL
Am J Pathol; 1979 Apr; 95(1):55-66. PubMed ID: 434113
[TBL] [Abstract][Full Text] [Related]
39. Current treatment options in hairy cell leukemia and hairy cell leukemia variant.
Robak T
Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083
[TBL] [Abstract][Full Text] [Related]
40. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
